MUC1 and neoplasm: The altered glycosylation of MUC1 allows it to function as a ligand for cell adhesion molecules such as selectins and intercellular adhesion molecule-1 (I-CAMs), facilitating the adherence of MUC1-expressing circulating tumor cells (CTCs) to endothelial cells and aiding in the establishment of secondary tumors at distant sites [64].